Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
enGene
company
About
enGene is a biotechnology company develops treatment for mucosal diseases through inducing therapeutic proteins of harmful proteins.
- 51 - 100
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $6.40M
- Industries
- Biotechnology,Diabetes,Genetics,Health Care
- Founded date
- Jan 1, 1999
- Number Of Employee
- 51 - 100
- Operating Status
- Active
enGene is a developer of a mucosal immunotherapy platform designed to treat inflammatory bowel disease and diabetes. The company's mucosal immunotherapy platform has developed a flexible nucleotide delivery technology targeting mucosal tissues to treat numerous prevalent, chronic diseases via the induction or suppression of protein expression levels, enabling physicians and doctors to regenerate physiologic, meal-regulated insulin secretion from the gut of subjects with diabetes.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$17.90M
enGene has raised a total of
$17.90M
in funding over 2 rounds. Their latest funding was raised on
Jan 26, 2015 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 26, 2015 | Series B | $11.50M | 1 | — | — | Detail |
| Mar 17, 2008 | Series A | $6.40M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
enGene is funded by 2 investors.
Adams, Harkness & Hill Technology Ventures
and Inbio Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
Inbio Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
